Financial reports
10-K/A
2023 FY
Annual report (amended)
29 Apr 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
ARS
2022 FY
Annual report to shareholders
28 Jun 23
10-Q
2023 Q1
Quarterly report
12 May 23
10-K
2022 FY
Annual report
8 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
11 May 22
Current reports
8-K
Changes in Registrant's Certifying Accountant
10 Apr 24
8-K
Other Events
29 Mar 24
8-K
CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates
28 Mar 24
8-K
Regulation FD Disclosure
13 Feb 24
8-K/A
CalciMedica Announces Private Placement of up to Approximately $55 Million
24 Jan 24
8-K
CalciMedica Announces Private Placement of up to Approximately $55 Million
22 Jan 24
8-K
CalciMedica Reports Third Quarter 2023 Financial Results and Provides Clinical & Corporate Updates
9 Nov 23
8-K
CalciMedica Announces Presentation of Initial Data from the CRSPA Study of Auxora at the 65th Annual ASH Meeting & Exposition
2 Nov 23
8-K
Other Events
11 Aug 23
8-K
CalciMedica Reports Second Quarter 2023 Financial Results and Provides Clinical & Corporate Updates
10 Aug 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
29 Mar 24
S-8
Registration of securities for employees
28 Mar 24
S-3
Shelf registration
31 Jan 24
S-3
Shelf registration
11 Aug 23
8-A12B
Registration of securities on exchange
13 Jun 23
S-8
Registration of securities for employees
12 May 23
S-3
Shelf registration
4 Apr 23
D
$9.11 mm in equity / options, sold $9.11 mm, 55 investors
4 Apr 23
S-8
Registration of securities for employees
19 Aug 22
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Mar 22
Proxies
DEFA14A
Additional proxy soliciting materials
28 Jun 23
DEF 14A
Definitive proxy
28 Jun 23
DEFA14A
Additional proxy soliciting materials
3 Mar 23
DEFA14A
Additional proxy soliciting materials
16 Feb 23
DEFM14A
Proxy related to merger
9 Feb 23
PRER14A
Preliminary revised proxy
6 Feb 23
PRER14A
Preliminary revised proxy
31 Jan 23
PRER14A
Preliminary revised proxy
20 Jan 23
PREM14A
Preliminary proxy related to merger
14 Dec 22
DEFA14A
Additional proxy soliciting materials
22 Nov 22
Other
EFFECT
Notice of effectiveness
12 Feb 24
CORRESP
Correspondence with SEC
7 Feb 24
UPLOAD
Letter from SEC
6 Feb 24
EFFECT
Notice of effectiveness
21 Aug 23
CORRESP
Correspondence with SEC
16 Aug 23
UPLOAD
Letter from SEC
15 Aug 23
CERT
Certification of approval for exchange listing
13 Jun 23
EFFECT
Notice of effectiveness
17 Apr 23
CORRESP
Correspondence with SEC
12 Apr 23
UPLOAD
Letter from SEC
10 Apr 23